Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 12
Phase 21
Phase 31

Trial Status

Completed2
Other1

Role Distribution

Principal Investigator2
Other Roles1
PI Rate67%

Activity Timeline

Clinical Trials (3)

NCT02004548Phase 1Completed
Phase I Clinical Study of Metatinib Tromethamine Tablet
Advanced or Metastatic Solid Tumors
Principalinvestigator
NCT02650375Phase 1Unknown
Study of Metatinib Tromethamine Tablet
Advanced or Metastatic CRCAdvanced or Metastatic Gastric CancerAdvanced or Metastatic Liver Cancer+1 more
Principalinvestigator

Research Network

Collaboration Network

11 collaborators·16 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Qin Yu, MD

West China Hospital

Related
1 trials

Shared therapeutic areas:

Advanced or Metastatic Solid Tumors

Worked with same sponsors:

Jiangsu Simcere Pharmaceutical Co., Ltd.
Collaborated on 1 trial
Similarity Score14%

You Lu, MD

West China Hospital

Related
18 trials

Shared therapeutic areas:

Advanced or Metastatic Solid Tumors

Worked with same sponsors:

Jiangsu Simcere Pharmaceutical Co., Ltd.
Collaborated on 1 trial
Similarity Score14%

Shukui Qin, MD

The PLA 81 Hospital

Related
1 trials

Shared therapeutic areas:

HCC

Worked with same sponsors:

Suzhou Zelgen Biopharmaceuticals Co.,LtdTigermed Consulting Co., Ltd
Collaborated on 1 trial
Similarity Score14%

Li Zheng, MD

West China Hospital

Related
1 trials

Shared therapeutic areas:

Advanced or Metastatic Solid Tumors

Worked with same sponsors:

Jiangsu Simcere Pharmaceutical Co., Ltd.
Collaborated on 1 trial
Similarity Score14%

Maozhi Liang, MD

West China Hospital

Related
1 trials

Shared therapeutic areas:

Advanced or Metastatic Solid Tumors

Worked with same sponsors:

Jiangsu Simcere Pharmaceutical Co., Ltd.
Collaborated on 1 trial
Similarity Score14%

Rong Chen, Ph.D

Eucure (Beijing) Biopharma Co., Ltd

Related
2 trials

Shared therapeutic areas:

HCC
Similarity Score5%

Abdullah Esmail, MD

Houston Methodist Neal Cancer Center

Related
3 trials

Shared therapeutic areas:

Advanced or Metastatic CRC
Similarity Score5%

Farshid Dayyani, MD, PhD

Chao Family Comprehensive Cancer Center

Related
4 trials

Shared therapeutic areas:

HCC
Similarity Score5%

Jeong Min Lee, MD

Seoul National University Hospital

Related
34 trials

Shared therapeutic areas:

HCC
Similarity Score5%

Crystal Denlinger, MD

Fox Chase Cancer Center

Related
3 trials

Shared therapeutic areas:

Advanced or Metastatic Gastric Cancer
Similarity Score5%

Publications (0)

No publications found for this investigator.

Clinical Trials (3)

Showing 3 of 3 trials

NCT02004548Phase 1PrincipalInvestigator

Phase I Clinical Study of Metatinib Tromethamine Tablet

Advanced or Metastatic Solid Tumors
Completed
NCT02645981Phase 2/3StudyChair

Efficacy and Safety of Donafenib in Patients With Advanced Hepatocellular Carcinoma

HCC
Completed
NCT02650375Phase 1PrincipalInvestigator

Study of Metatinib Tromethamine Tablet

Advanced or Metastatic CRCAdvanced or Metastatic Gastric CancerAdvanced or Metastatic Liver Cancer+1 more
Unknown

All 3 trials loaded